Convalescent Methylene Blue Treated (MBT) Plasma
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Convalescent Methylene Blue Treated (MBT) Plasma, covering 2021-03-03 to 2021-03-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) [Phase 2]